Skip to main content

Advertisement

SpringerLink
Log in

Cofactors in human papillomavirus infection and cervical carcinogenesis

  • Gynecologic Oncology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Objective

This study aimed to identify the effect of various risk factors as the promoters of HPV infection, and to identify which HPV-positive women may have an increased risk of developing cervical cancer.

Methods

Smear preparations were examined and classified according to the Bethesda system. HPV-DNA detection and genotyping was carried out using polymerase chain reaction combined with reverse hybridization line-probe assays. Age, smoking habit, age at first sexual intercourse, number of sexual partners, number of term births, contraceptive method, progesterone therapy, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were recorded.

Results

642 women (96 women with abnormal cervical cytology and 546 women with normal cytology) provided cervical samples. Smoking habit, number of sexual partners, number of term births, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as the promoters of HPV infection. History of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as cofactors affecting progression from HPV infection to cervical cancer. Neither of contraceptive methods studied was related to HPV infection or coexistence with malign transformation to cervical cancer.

Conclusion

Information gathered from this study could be used to prioritize limited screening and treatment services to woman who have specific characteristics that may put them at an increased risk of HPV infection. Additionally, by identifying which women have a higher risk of cervical cancer; it may be possible to reduce the number of unnecessary colposcopies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walboomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL (2001) High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101–106

    PubMed  CAS  Google Scholar 

  2. Winer RL, Lee SK, Hughes JP, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157:218–226

    Article  PubMed  Google Scholar 

  3. Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M (2002) A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94:1406–1414

    Article  PubMed  Google Scholar 

  4. Lundberg GD (1989) The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis. JAMA 262:931–934

    Article  Google Scholar 

  5. Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902–907

    Article  PubMed  CAS  Google Scholar 

  6. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779–787

    Article  PubMed  Google Scholar 

  7. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17–27

    Article  PubMed  Google Scholar 

  8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    Article  PubMed  CAS  Google Scholar 

  9. Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527

    Article  PubMed  Google Scholar 

  10. Munoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285

    Article  PubMed  CAS  Google Scholar 

  11. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265

    Article  PubMed  CAS  Google Scholar 

  12. Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni JF (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47:1706–1711

    PubMed  CAS  Google Scholar 

  13. Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM (1998) Causes of cervical cancer in the Philippines: a case–control study. J Natl Cancer Inst 90:43–49

    Article  PubMed  CAS  Google Scholar 

  14. Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM (1998) Risk factors for cervical cancer in Thailand: a case–control study. J Natl Cancer Inst 90:50–57

    Article  PubMed  CAS  Google Scholar 

  15. Lacey JVJ, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12:153–161

    Article  PubMed  Google Scholar 

  16. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83:1565–1572

    Article  PubMed  CAS  Google Scholar 

  17. Altekruse SF, Lacey JVJ, Brinton LA, Gravitt PE, Silverberg SG, Barnes WAJ, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003) Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 188:657–663

    Article  PubMed  Google Scholar 

  18. Munoz N, Franceschi S, Bosetti C, Moreno V, Smith JS, Shah KV, Meijer CJ, Bosch F (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 359:1093–1101

    Article  PubMed  Google Scholar 

  19. Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors for adenocarcinoma of the cervix: a case–control study. Br J Cancer 57:201–204

    Article  PubMed  CAS  Google Scholar 

  20. Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F (1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51:301–306

    Article  PubMed  CAS  Google Scholar 

  21. Hildesheim A, Herrero R, Castle P, Wacholder S, Bratti M, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M (2001) HPV cofactors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226

    Article  PubMed  CAS  Google Scholar 

  22. Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 58:820–824

    Article  PubMed  CAS  Google Scholar 

  23. Bjorge T, Kravdal O (1996) Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. Cancer Causes Control 7:351–357

    Article  PubMed  CAS  Google Scholar 

  24. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case–control study. Lancet 359:1085–1092

    Article  PubMed  CAS  Google Scholar 

  25. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159–1167

    Article  PubMed  Google Scholar 

  26. La Vecchia C, Altieri A, Franceschi S, Tavani A (2001) Oral contraceptives and cancer: an update. Drug Saf 24:741–754

    Article  PubMed  CAS  Google Scholar 

  27. Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 29:725–735

    Article  PubMed  Google Scholar 

  28. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ (1996) Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601–606

    Article  PubMed  CAS  Google Scholar 

  29. Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L (2001) Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 10:441–449

    Article  PubMed  CAS  Google Scholar 

  30. Thomas DB, Ray RM (1995) Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives. Contraception 52:307–312

    Article  PubMed  CAS  Google Scholar 

  31. Schmauz R, Okong P, de Villiers EM et al (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805–809

    Article  PubMed  CAS  Google Scholar 

  32. Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604–1613

    Article  PubMed  CAS  Google Scholar 

  33. Gravitt PE, Castle PE (2001) Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA 285:1703–1704

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No financial support was received for this paper.

Conflict of interest

The authors declare no competing interest.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology Clinic III, Izmir Ataturk Training and Research Hospital, Izmir, Turkey

    Hakan Yetimalar, Burcu Kasap, Kulal Cukurova, Askin Yildiz & Adnan Keklik

  2. Department of Obstetrics and Gynecology Clinic II, Izmir Ataturk Training and Research Hospital, Izmir, Turkey

    Ferit Soylu

Authors
  1. Hakan Yetimalar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burcu Kasap
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kulal Cukurova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Askin Yildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Adnan Keklik
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ferit Soylu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Burcu Kasap.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yetimalar, H., Kasap, B., Cukurova, K. et al. Cofactors in human papillomavirus infection and cervical carcinogenesis. Arch Gynecol Obstet 285, 805–810 (2012). https://doi.org/10.1007/s00404-011-2034-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-011-2034-3

Keywords

Search

Navigation